ReShape Lifesciences (RSLS) Q2 2025 Earnings

14AugConfirmed
Q4 2024
Q2 2025
Q2 2025
Q2 2025
-101.5
-61.16
-20.82
19.52

Details

Expected EPS
N/A
Actual EPS
-2.25
Surprise EPS
-2.25
Surprise Percent
+∞%

Description

ReShape Lifesciences (RSLS) has reported earnings of -2.25 per share for Q2 2025.

0 Comments

Share your thoughts